Recap: Harvard Bioscience Q1 Earnings

Harvard Bioscience HBIO reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Harvard Bioscience missed estimated earnings by 20.0%, reporting an EPS of $0.04 versus an estimate of $0.05.

Revenue was up $1.79 million from the same period last year.

Last quarter the company missed on EPS by $0.02 which was followed by a 7.94% increase in the share price the next day.

Here's a look at Harvard Bioscience's past performance:

Quarter	Q4 2021	Q3 2021	Q2 2021	Q1 2021
EPS Estimate	0.10	0.06	0.06	0.03
EPS Actual	0.08	0.06	0.06	0.05
Revenue Estimate	32.96M	27.91M	27.67M	25.73M
Revenue Actual	33.05M	29.66M	29.20M	26.99M

To track all earnings releases for Harvard Bioscience visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar